Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease

2015/05/29 by Johannie du Plessis, Jos van Pelt, Hannelie Korf +19 · 26 citations
Medicine · #Liver Disease Diagnosis and Treatment #Adipokines, Inflammation, and Metabolic Diseases #Cardiovascular Disease and Adiposity

paper · pdf · doi:10.1053/j.gastro.2015.05.044

Cited by

• The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
• Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame. [europepmc]
• Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. [europepmc]
• Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. [europepmc]
• The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. [europepmc]
• Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. [europepmc]
• Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. [europepmc]
• Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide. [europepmc]
• Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis. [europepmc]
• Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. [europepmc]
• Adipocyte Death Preferentially Induces Liver Injury and Inflammation Through the Activation of Chemokine (C-C Motif) Receptor 2-Positive Macrophages and Lipolysis. [europepmc]
• The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. [europepmc]
• Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders. [europepmc]
• What lipodystrophies teach us about the metabolic syndrome. [europepmc]
• Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution. [europepmc]
• Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. [europepmc]
• Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. [europepmc]
• Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. [europepmc]
• Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. [europepmc]
• The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease. [europepmc]
• Adipose Tissue Macrophage Polarization in Healthy and Unhealthy Obesity. [europepmc]
• Mechanisms and disease consequences of nonalcoholic fatty liver disease. [europepmc]
• Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2. [europepmc]
• It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? [europepmc]
• Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death. [europepmc]
• Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. [europepmc]